home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

315 rows where filing_period = "second_quarter", filing_year = 2024 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • MED · 315 ✖

filing_year 1

  • 2024 · 315 ✖

filing_period 1

  • second_quarter · 315 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
3183379 FRANCIS EDWARD & CRONIN, INC. c2ece435-ec2f-43a9-9e7f-3418499b6483 2T FRANCIS EDWARD & CRONIN, INC. 311314 USAGAINSTALZHEIMER'S 2024 second_quarter MED Legislation related to the treatment, detection, and prevention of Alzheimer's disease Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2024-05-14T18:21:42-04:00
3183957 BLUEBIRD STRATEGIES 1712d342-7198-4f13-95f6-acc3d431d380 Q2 BLUEBIRD STRATEGIES 401105447 MYRIAD GENETICS, INC. 2024 second_quarter MED Legislation to regulate clinical testing/labs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-06-03T14:14:18-04:00
3183961 BLUEBIRD STRATEGIES b44a3bde-efc8-4268-9e6c-f0f60a38ca21 Q2 BLUEBIRD STRATEGIES 401105447 MYOTONIC 2024 second_quarter MED Increasing funding for Myotonic Dystrophy research. Fiscal Year 2025 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-06-03T14:17:46-04:00
3184433 MCDERMOTT+ LLC 68818057-4a15-4ab5-a506-ddf0ae4cdf57 Q2 MCDERMOTT+ LLC 401103287 VERILY LIFE SCIENCES LLC 2024 second_quarter MED Efforts relating to artificial intelligence, wastewater surveillance and drug and device innovation. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-06-26T10:00:05-04:00
3184488 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) 0e26c757-dcbc-439f-8a17-24f71d88df84 Q2 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) 292538 SONIC HEALTHCARE USA 2024 second_quarter MED Issues relating to the regulation of laboratory developed tests, the VALID Act, issues relating to PAMA (the SALSA Bill), federal policies relating to the implementation of the anti-kickback requirements of the Support for Patients and Communities Act. Physician Lab Fee schedule. Anatomic Fee Schedule and Surprise Billing. COVID Testing and billing procedures. COVID Vaccine Federal Mandate. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-06-27T11:16:55-04:00
3184629 AUBURN HEALTH STRATEGIES, LLC c3b7cd3f-b917-4d90-8d52-5be54c745360 Q2 AUBURN HEALTH STRATEGIES, LLC 292697 AMERICAN PROFICIENCY INSTITUTE 2024 second_quarter MED proficiency testing for clinical laboratories SENATE     0 0 2024-06-29T18:42:32-04:00
3184637 OCAL LOBBYING GROUP 6d6ea527-f824-444c-aced-aa39ad82be04 Q2 OCAL LOBBYING GROUP 401106825 SAMERA S.A. 2024 second_quarter MED Obtain funding for Tuberculosis monitoring.       0 0 2024-06-30T09:34:34-04:00
3184890 AMERICAN COLLEGE OF CLINICAL PHARMACY 67e8a608-5a36-4b84-abd7-bb73dee5d2c4 Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2024 second_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2024-07-01T10:54:57-04:00
3184980 THE HARRIS FIRM 7550252e-f145-4a69-b2e5-4880c32a19a8 Q2 THE HARRIS FIRM 68376 HOLISTIC INDUSTRIES INC. 2024 second_quarter MED Issues pertaining to cannabis CSA scheduling. Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE 50000   0 0 2024-07-01T13:05:09-04:00
3185005 OLD NORTH STRATEGIES, LLC 4d1e57ce-8cad-44f4-951b-6f4ff76671d3 Q2 OLD NORTH STRATEGIES, LLC 401106174 EXELA PHARMA SCIENCES, LLC 2024 second_quarter MED supply chain & FDA issues HOUSE OF REPRESENTATIVES,SENATE 108000   0 0 2024-07-01T13:18:29-04:00
3185073 REPUBLIC CONSULTING, LLC d155dca3-4598-46a2-8611-2a3831d1dea9 Q2 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2024 second_quarter MED Monitor Health Data Policy. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2024-07-01T14:44:07-04:00
3185151 HELIX, INC. 1f87ea82-5fb7-4843-aeec-1e3b440e02d5 Q2 HELIX, INC. 401106164 HELIX, INC. 2024 second_quarter MED Oversight of Lab Developed Tests, express legislative authority. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2024-07-01T16:07:19-04:00
3185519 MAGILL ASSOCIATES, LLC 54d4ada6-16da-46ec-99a8-171e863eb8e8 Q2 MAGILL ASSOCIATES, LLC 401103511 THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES 2024 second_quarter MED FY 2025 appropriations for the development of a synthetic vaccine HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-07-02T14:32:35-04:00
3185657 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 596b20c2-f147-4dc0-a8cb-fa185ca009fc Q2 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2024 second_quarter MED NIH funding, PACT Act, Accelerating Kids Access Act, NIH reform Senate HELP Minority RFI, genomic testing, LDT testing FDA rule, NICHD workforce reform including K12, NIH reform Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   34865 0 0 2024-07-03T08:15:00-04:00
3185727 CAPSTONE NATIONAL PARTNERS 7b1215e6-02a9-4fc5-a60a-273a6241e8a0 Q2 CAPSTONE NATIONAL PARTNERS 8214 ATTERX BIOTHERAPEUTICS 2024 second_quarter MED research funding HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2024-07-03T11:03:49-04:00
3185889 A10 ASSOCIATES, LLC 7d8beb32-01c2-45e8-b481-845acf757434 Q2 A10 ASSOCIATES, LLC 401105040 AESTHETIC MEDICAL PROVIDERS OF NEW HAMPSHIRE 2024 second_quarter MED Issues promoting the interests of professionals providing medical aesthetic services. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-07-03T15:20:50-04:00
3185970 FRANCIS EDWARD & CRONIN, INC. 84e1babf-73aa-4b6a-a1ac-35313d8f9202 Q2 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2024 second_quarter MED Legislation related to Alzheimer's disease research Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2024-07-04T14:28:59-04:00
3186436 MASON STREET CONSULTING, LLC 3edb4690-dba8-419b-8ddb-cd46ec98adc6 Q2 MASON STREET CONSULTING, LLC 401105150 PERIMETER MEDICAL IMAGING 2024 second_quarter MED Advanced Research Projects Agency for Health (ARPA-H). Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2024-07-07T09:04:53-04:00
3186746 IMPACT MANAGEMENT GROUP 9f3121f9-c225-479f-b5e9-93a8a3b07b2b Q2 IMPACT MANAGEMENT GROUP 401104137 ARKANSAS RESEARCH ALLIANCE 2024 second_quarter MED On behalf of client support continued and future funding for clinical research programs in Arkansas HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-07-08T14:13:36-04:00
3186819 IMPACT MANAGEMENT GROUP 68d33089-2f6b-4fef-bd04-9bb46cd06269 Q2 IMPACT MANAGEMENT GROUP 401104137 CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC. 2024 second_quarter MED Supporting the passage of H.R. 3173 - Improving Seniors' Timely Access to Care Act of 2021 HOUSE OF REPRESENTATIVES     0 0 2024-07-08T15:22:41-04:00
3186870 THE LIVINGSTON GROUP, LLC 2b62ee29-8300-44e1-a58f-3f21909203c6 Q2 THE LIVINGSTON GROUP, LLC 49635 INNOVATIVE VACCINE TECHNOLOGIES 2024 second_quarter MED FY2025 appropriations for the development of a synthetic vaccine HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-07-08T16:31:59-04:00
3187041 WATKINS & EAGER PLLC 41459312-8c34-47d6-84a0-123ca685c05b Q2 WATKINS & EAGER PLLC 401104403 NATIONAL FRAGILE X FOUNDATION 2024 second_quarter MED Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2024-07-09T11:13:23-04:00
3187273 RAY C CULVER III 200712a1-435c-4b3e-a2ec-ca9e52ddbb7b Q2 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2024 second_quarter MED Funding for USDA ARS human nutrition research in the FY2025 House and Senate appropriation bills. HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-07-09T13:19:59-04:00
3187421 GABBERT CONSULTING CO LLC 5495c707-fd65-4c53-a7c6-c7b4abc9cffd Q2 GABBERT CONSULTING CO LLC 401105309 CHIPPS, CAFFREY AND DUBILIER, P. S. C. 2024 second_quarter MED FDA issues final rule applying medical device rules to laboratory developed tests HOUSE OF REPRESENTATIVES 9000   0 0 2024-07-09T15:18:47-04:00
3187555 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) b37057b3-21b0-4991-a40c-7ec7ff4af929 Q2 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2970 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2024 second_quarter MED none     189000 0 0 2024-07-09T16:53:10-04:00
3187867 FLORIDA STATE UNIVERSITY 93d4b2f3-fa0f-4b2e-84a4-166412364535 Q2 FLORIDA STATE UNIVERSITY 14952 FLORIDA STATE UNIVERSITY 2024 second_quarter MED FY 2025 Labor HHS Education Appropriations Act - NIH (NINDS) HOUSE OF REPRESENTATIVES,SENATE   38000 0 0 2024-07-10T12:45:03-04:00
3188095 UNIVERSITY OF KENTUCKY 554942a4-806c-401e-a6ef-2a49ad101946 Q2 UNIVERSITY OF KENTUCKY 400287372 UNIVERSITY OF KENTUCKY 2024 second_quarter MED NCI funding for FY24 HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   158183 0 0 2024-07-10T14:58:11-04:00
3188245 LOBBYIT.COM 6ccc0070-9096-43d6-a493-6920c373dd06 2T LOBBYIT.COM 400487397 BRAIN ANEURYSM FOUNDATION 2024 second_quarter MED Advocate for the passage of Ellie's Law (H.R. 902, S. 895) Creation of a dedicated Brain Aneurysm Caucus Appropriation Requests HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2024-07-10T16:22:45-04:00
3188461 WILLIAM SCHMIDT 411f1f28-c832-4290-8eea-ac3341f49fea 2T WILLIAM SCHMIDT 401107557 PULMONARY FIBROSIS FOUNDATION 2024 second_quarter MED Funding for the National Institutes of Health Funding for the Congressionally Directed Medical Research Program at the Department of Defense HOUSE OF REPRESENTATIVES,SENATE     0 1 2024-07-11T09:51:29-04:00
3189074 THE DLM GROUP c0626ed5-82c0-4360-b45e-5bac5b3eccdf Q2 THE DLM GROUP 313794 GENESIS HEALTH CARE, INC. 2024 second_quarter MED no activity HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-07-11T16:31:44-04:00
3189501 HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. 5a4c14e3-0e2d-4822-8374-39b231d07cc3 Q2 HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. 52925 HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC. 2024 second_quarter MED MED HR 3226/S 1573: Prematurity Research Expansion and Education for Mothers who Deliver Infants Early (PREEMIE) Reauthorization Act of 2023 All Provisions This bill would reauthorize critical federal research, education and care to reduce preterm birth and infant mortality. MED HR 4534/S 2245 - Women and Lung Cancer Research and Preventative Services Act of 2023 All provisions This bill requires a review of women and lung cancer studies, provides for a public education campaign, and more. HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2024-07-12T12:53:01-04:00
3189659 COMPASS GOVERNMENT RELATIONS PARTNERS, LLC bdc0b9fb-0fa5-4504-bcbe-f8aee0dba04d Q2 COMPASS GOVERNMENT RELATIONS PARTNERS, LLC 401106533 COALITION FOR INNOVATIVE LABORATORY TESTING, INC. 2024 second_quarter MED Matters pertaining to the VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses; Docket No. FDA-2023-N-2177 (FDA's release of the Final Rule on LDTs HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA)     0 0 2024-07-12T14:25:00-04:00
3189783 BEN BARNES GROUP LP 232226fb-21af-4e12-94b7-b5f230d73dba Q2 BEN BARNES GROUP LP 5415 CLENE NANOMEDICINE, INC. 2024 second_quarter MED ALS HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2024-07-12T15:33:09-04:00
3189846 BEN BARNES GROUP LP 501272ae-38ba-4d88-8310-4c266f185f6e Q2 BEN BARNES GROUP LP 5415 HUNTSMAN CORPORATION 2024 second_quarter MED CMS Medicare HOUSE OF REPRESENTATIVES,SENATE 18750   0 0 2024-07-12T15:56:34-04:00
3190173 FORBES-TATE 87922a1f-a660-482c-8a6f-40281e17c943 Q2 FORBES-TATE 400976792 AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION 2024 second_quarter MED Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-07-13T11:21:05-04:00
3190186 FORBES-TATE 996773a1-53cb-4111-b7e9-1fe78d0201cd Q2 FORBES-TATE 400976792 AMGEN USA, INC. 2024 second_quarter MED Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2024-07-13T11:49:40-04:00
3190699 FEDERAL SOLUTIONS, LLC a406bae2-e628-4687-b404-8fedb588aa56 Q2 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2024 second_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-07-14T13:00:29-04:00
3190778 FORBES-TATE 85346aa1-3c14-4384-bbf0-643a27df37fe Q2 FORBES-TATE 400976792 CALIFORNIA LIFE SCIENCES ASSOCIATION 2024 second_quarter MED Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169). HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-07-14T14:10:39-04:00
3190837 FORBES-TATE c12d9fc2-840f-41f2-994e-091fe10e6026 Q2 FORBES-TATE 400976792 COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION 2024 second_quarter MED Issues pertaining to government-wide federal regulation of cannabis. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-07-14T14:58:03-04:00
3190957 FORBES-TATE cea35ed4-37de-4c4f-88eb-3e3114c0da2b Q2 FORBES-TATE 400976792 CSL BEHRING 2024 second_quarter MED Issues related to Rx pricing; Issues related to plasma and plasma derived therapies; Issues related to H.R. - 6465 Preserving Life-saving Access to Specialty Medicines in America Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2024-07-14T15:56:42-04:00
3191212 CORNERSTONE GOVERNMENT AFFAIRS, INC. 174feee1-c7cb-45df-be70-011c13714111 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 JOHNS HOPKINS UNIVERSITY 2024 second_quarter MED Presidential management fellowships; advised on Francis Scott Key Bridge collapse; advised on fiscal year 2025 appropriations; advised on Medicare reimbursement; advised on Medicare Graduate Medical Education and Childrens Hospital Graduate Medical Education issues; telehealth; Committee on Foreign Investment in the United States; public health; artificial intelligence; facilities and administration costs; endowment tax legislative and regulatory issues; advised on Lower Cost, More Transparency Act, H.R. 5378; advised on Antisemitism Awareness Act, H.R. 6090; advised on S.4115/H.R. 7725, the Embracing anti-Discrimination, Unbiased Curricula, and Advancing Truth in Education (EDUCATE) Act; advised on Accreditation for College Excellence (ACE) Act, H.R. 3724; advised on Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act, H.R. 5933/S.3362; advised on workforce Pell grant issues. HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE 60000   0 0 2024-07-14T23:42:51-04:00
3191336 PONTIS PARTNERS, LLC a38925fd-78f8-4f79-837a-1438a48764ef Q2 PONTIS PARTNERS, LLC 401107566 KIDNEY TRANSPLANT COLLABORATIVE 2024 second_quarter MED Enactment of The Living Organ Volunteer Engagement (LOVE) Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-07-15T09:40:52-04:00
3191613 CORNERSTONE GOVERNMENT AFFAIRS, INC. 459de23c-31df-4156-b062-481b61d569b9 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 OU MEDICINE, INC. 2024 second_quarter MED Research and development of medical programs in partnership with Department of Health and Human Services and other federal agencies Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-07-15T11:33:13-04:00
3191691 CORNERSTONE GOVERNMENT AFFAIRS, INC. 7ff7c775-cc31-4552-9d7e-c74fbd3f4667 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 HAZELDEN BETTY FORD FOUNDATION 2024 second_quarter MED Educate key government stakeholders on Hazelden Betty Ford Foundation activities in support of substance use and mental health for US Service members and Veterans. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-07-15T11:59:46-04:00
3192101 TIBER CREEK GROUP 6f115ae8-2ed8-4e6f-9dc7-d51e18f1b730 Q2 TIBER CREEK GROUP 20744 JAZZ PHARMACEUTICALS 2024 second_quarter MED Issues related to cannabis research; Issues related to the FDA; Issues related to cannabis research at Health and Human Services. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-07-15T14:06:43-04:00
3192275 CORNERSTONE GOVERNMENT AFFAIRS, INC. ecb879ef-c09e-4837-93e5-e61b81d786b4 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 MMV MEDICINES FOR MALARIA VENTURE 2024 second_quarter MED The purpose was to increase funding for malaria research in the Department of Defense. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-07-15T14:57:41-04:00
3192413 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 7d5aebe6-9702-4f08-a0e7-e8d9d18ff115 Q2 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 52105 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 2024 second_quarter MED Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP) PRORP is a competitive grant program that funds research pertaining to extremity war injuries to address the most significant gaps for military personnel with orthopaedic injuries. HOUSE OF REPRESENTATIVES,SENATE   433848 0 0 2024-07-15T15:46:35-04:00
3192510 SQUIRE PATTON BOGGS 54b4f92d-a359-49dc-b3e4-ec011a32b959 Q2 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2024 second_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 80000   0 0 2024-07-15T16:18:12-04:00
3192733 DQB INTERNATIONAL 90316f9e-bfbe-43a7-9067-44d593e0dd03 Q2 DQB INTERNATIONAL 291834 TEXAS BIOMEDICAL RESEARCH INSTITUTE 2024 second_quarter MED FY 2024 Labor, HHS Appropriations Bill and Pandemic and All-Hazards Preparedness Reauthorization Act HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-07-15T17:39:05-04:00
3192766 2359 STRATEGIES 29e25151-6bec-4fe0-b9c4-3c272b8dd755 Q2 2359 STRATEGIES 401106114 TRAVERE THERAPEUTICS 2024 second_quarter MED Rare kidney disease HOUSE OF REPRESENTATIVES,SENATE 12000   0 0 2024-07-15T17:54:19-04:00
3192995 CORNERSTONE GOVERNMENT AFFAIRS, INC. 246f7959-9e81-443b-96fc-f4cdcf71d8cd Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 NIRSENSE, LLC (FKA BIONICA LABS) 2024 second_quarter MED Educated key government stakeholders on NIRSenses activities and technologies in support of the Armed Forces and support Defense appropriations and authorization requests. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2024-07-15T21:39:38-04:00
3193002 CORNERSTONE GOVERNMENT AFFAIRS, INC. 8ad14392-f5b4-4625-bef6-bc7c0edd84ac Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 SCIPERIO INC. 2024 second_quarter MED Educated key government stakeholders on Sciperio, Inc.s technology and manufacturing capabilities in support of the Department of Defense. Provide support for Defense appropriations requests. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2024-07-15T21:50:22-04:00
3193005 CORNERSTONE GOVERNMENT AFFAIRS, INC. fb2c0969-65a2-4c5c-97b8-ceacc5d4af74 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE GENEVA FOUNDATION 2024 second_quarter MED Educated key government stakeholders on The Geneva Foundations research and development activities in support of US Service members. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-07-15T21:52:25-04:00
3193008 CORNERSTONE GOVERNMENT AFFAIRS, INC. d4b5296f-5a54-4da9-af47-7e6fd32662e8 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THERADAPTIVE, INC. 2024 second_quarter MED Educated key government stakeholders on Theradaptives products applicable to the military and support appropriations requests. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-07-15T21:58:08-04:00
3193024 CORNERSTONE GOVERNMENT AFFAIRS, INC. 9cd797a5-51b0-4857-8e7f-e10b73a06b58 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 MOBERG ANALYTICS, INC. 2024 second_quarter MED Educated key government stakeholders on Mobergs research and development activities in support of US Service members and support Defense appropriations. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-07-15T22:16:09-04:00
3193083 AMERICAN SOCIETY OF ADDICTION MEDICINE 54f41762-6440-4e9d-b5b3-f6b156a19d08 Q2 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2024 second_quarter MED Advocated for increased FY25 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY25 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M). Advocated for at least $10.5 billion for HRSA programs in the FY 2025 Labor, Health and Human Services, Education, and Related Agencies appropriations bill. Joined coalition letter opposing any legislation that would bar medical schools from receiving federal funding if they engage in activities such as having a Diversity, Equity and Inclusion (DEI) office and/or provide education on structural or institutional racism. Advocated for passage of H.R. 7050 - the Substance Use Disorder Workforce Act of 2024, with a recommendation that the Senate include additional monetary incentives in the bill for physicians training as addiction specialists. Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for S. 1165/ HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Advocated for HR 3074/S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Advocated for draft legislation that would provide Medicare coverage for evidence-based residential SUD services. Advocated for various substance use disorder workforce and coverage policy changes, including the SUPPORT for Patients and Communities Reauthorization Act (S. 3393). Advocated for certain annual increases for Medicare office based SUD bundled codes. Advocated for H.R.5163/S. 3193 - Telehealth Response… Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   40000 0 0 2024-07-16T06:55:29-04:00
3193160 IMPACT HEALTH POLICY PARTNERS fb33c07d-5ff5-4648-9cf4-62ec65887b3d Q2 IMPACT HEALTH POLICY PARTNERS 401104696 ABBOTT LABORATORIES 2024 second_quarter MED Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-07-16T08:17:23-04:00
3193169 IMPACT HEALTH POLICY PARTNERS c373ae4e-1f87-41ea-a940-891216885ca2 Q2 IMPACT HEALTH POLICY PARTNERS 401104696 CHILDREN'S HOSPITAL COLORADO 2024 second_quarter MED Issues related to pediatric research and children's hospital graduate medical education. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-07-16T08:20:44-04:00
3193186 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 5b7aee8b-bb27-4f2f-aa00-a475a069214f Q2 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 INTUITIVE SURGICAL, INC. 2024 second_quarter MED Lobbying related to health care issues. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-07-16T08:25:54-04:00
3193188 IMPACT HEALTH POLICY PARTNERS 6e1f7b4f-c655-4ab2-b05e-8f138442cae3 Q2 IMPACT HEALTH POLICY PARTNERS 401104696 HACKENSACK MERIDIAN HEALTH 2024 second_quarter MED Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 40000   0 0 2024-07-16T08:26:30-04:00
3193550 MANATT, PHELPS, AND PHILLIPS dd11e0d4-23c9-4fc3-86e5-b3332ecf469c Q2 MANATT, PHELPS, AND PHILLIPS 23645 LOMA LINDA UNIVERSITY MEDICAL CENTER 2024 second_quarter MED Healthcare, Legislation Impacting Hospitals, Federal Funding/CPF and CDF   140000   0 0 2024-07-16T10:36:35-04:00
3193563 MANATT, PHELPS, AND PHILLIPS dc4193fc-2bcc-4280-920c-c3c74cf0a6ce Q2 MANATT, PHELPS, AND PHILLIPS 23645 MEDISYS HEALTH NETWORK 2024 second_quarter MED Provider Relief and COVID funding and other healthcare issues; Community Project Funding   40000   0 0 2024-07-16T10:39:13-04:00
3193873 CONLON PUBLIC STRATEGIES e7de8c8b-d052-4e49-9b38-35ab12f8bcd5 Q2 CONLON PUBLIC STRATEGIES 306294 CHESTNUT HEALTH SYSTEMS 2024 second_quarter MED Educate on the work of Chestnut health systems and explore grant opportunities. Agency for Healthcare Research & Quality (AHRQ),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 10000   0 0 2024-07-16T11:53:56-04:00
3194160 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) c8d75be8-5808-42e6-91fe-479ee8a02829 Q2 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 401103161 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 2024 second_quarter MED NONE     10000 0 0 2024-07-16T13:47:51-04:00
3194687 BURRELL INTERNATIONAL GROUP LLC e84a7b91-8c25-4fc3-b57b-a590c69921ce 2T BURRELL INTERNATIONAL GROUP LLC 401103483 ARSENAL MEDICAL, INC. 2024 second_quarter MED DoD Appropriation for Research and Development for hemorrhage control HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2024-07-16T16:03:59-04:00
3194997 MICHAEL N. MCCARTY LAW OFFICE PLLC c74aedb4-1c47-4a4f-a9e1-ad2bdf66eaaa Q2 MICHAEL N. MCCARTY LAW OFFICE PLLC 401104300 AMERICAN MEDICAL TECHNOLOGISTS 2024 second_quarter MED Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory to "harmonize" clinical diagnostic test results and to establish pediatric reference intervals for in vitro diagnostic (IVD) tests performed on children; support enhanced funding for CDC's Advanced Molecular Detection program; monitor legislation to regulate laboratory-developed IVD tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to expansion of health workforce programs administered by the Health Resource and Services Administration, funding for the Public Health Workforce Loan Repayment Program and the Bio-Preparedness Workforce Pilot Program; support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477). HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-07-16T19:26:04-04:00
3195072 COMMONWEALTH STRATEGIC PARTNERS, LLC 0581a558-5258-4744-974c-5d7d1bf495ad Q2 COMMONWEALTH STRATEGIC PARTNERS, LLC 401103486 PEOPLE FOR THE ETHICAL TREATMENT OF ANIMALS (PETA) 2024 second_quarter MED Issues related to animal testing and experimentation, specifically H.R. 4757 Cease Animal Research Grants Overseas (CARGO) Act. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-07-16T20:31:24-04:00
3195076 COMMONWEALTH STRATEGIC PARTNERS, LLC 66db6967-8bf2-42dc-81f3-bea2ba0a481c Q2 COMMONWEALTH STRATEGIC PARTNERS, LLC 401103486 AMERICAN ASSOCIATION OF SUICIDOLOGY 2024 second_quarter MED Support policies and research for suicide awareness, training, outreach, and prevention, including but not limited to robust HHS funding and improvements to the 988 program HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-07-16T20:32:50-04:00
3195161 CORNERSTONE GOVERNMENT AFFAIRS, INC. 2b098a7a-4681-4266-93aa-a283e60d4ba5 Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 BIONTECH US INC. 2024 second_quarter MED Educated policymakers on BioNTech's federally funded research and development activities. HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2024-07-16T22:26:51-04:00
3195164 CORNERSTONE GOVERNMENT AFFAIRS, INC. e825f803-60c6-4528-88f9-df1aff1d2d6f Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 ARMR SYSTEMS INC 2024 second_quarter MED Educated policymakers on ARMR's research and development activities in support of US Service members and Defense appropriations. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-07-16T22:30:50-04:00
3195172 CORNERSTONE GOVERNMENT AFFAIRS, INC. a5726ec6-e090-4bbe-b9de-17276b8272ec Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 VOCXI HEALTH 2024 second_quarter MED Educated policymakers and key government stakeholders on VOCxi Health research and development activities in support of US Service members and Defense appropriations. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-07-16T22:35:53-04:00
3195175 CORNERSTONE GOVERNMENT AFFAIRS, INC. 1ca08b59-2f5d-4bfc-b56b-a1de12b3d90c Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 LUMEN BIOSCIENCE, INC. 2024 second_quarter MED Educated policymakers and key government stakeholders on Lumens research and development activities in support of US Service members and Defense appropriations. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-07-16T22:44:09-04:00
3195182 CORNERSTONE GOVERNMENT AFFAIRS, INC. 18d0e906-9842-4fd8-aeb6-b2ed0c8e033d Q2 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 THE UNIVERSITY OF TEXAS SYSTEM 2024 second_quarter MED Assessing the Systems R&D funding opportunities, designing strategies to pursue funding, and securing funding for research priorities. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2024-07-16T22:58:38-04:00
3195344 IPOLICY SOLUTIONS 3c925461-95af-4d68-9a7c-0997064e0507 Q2 IPOLICY SOLUTIONS 401105127 ASSOCIATION FOR MOLECULAR PATHOLOGY 2024 second_quarter MED No bill #: legislation to modernize CLIA H.R.2369 - VALID Act of 2023 FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests" HOUSE OF REPRESENTATIVES,SENATE 70500   0 0 2024-07-17T09:50:48-04:00
3195361 IPOLICY SOLUTIONS 507207f0-db7d-4b4b-83d5-c7b7df2b9829 Q2 IPOLICY SOLUTIONS 401105127 INVITAE INC. 2024 second_quarter MED H.R.2369 - VALID Act of 2023 FDA Final Rule: Laboratory Developed Tests HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2024-07-17T09:55:21-04:00
3195393 STRATEGIC MARKETING INNOVATIONS 387fadbe-4627-43ae-b92d-8b39b59e99ab Q2 STRATEGIC MARKETING INNOVATIONS 60550 PREVENT BIOMETRICS 2024 second_quarter MED Defense appropriations for medical technology HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2024-07-17T10:03:59-04:00
3195701 SQUIRE PATTON BOGGS 5abc9883-2ea5-4c10-9e30-74423bfd52aa Q2 SQUIRE PATTON BOGGS 30906 LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. 2024 second_quarter MED Funding support for federally qualified health centers; reauthorization of programs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-07-17T11:52:12-04:00
3195833 F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES 33110e63-52e9-466d-a8a4-853da7012b29 Q2 F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES 18411 F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES 2024 second_quarter MED H.R. 2369 The Verifying Accurate Leading-edge IVCT Development Act, Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R. 3795 The Diagnostics Testing Preparedness Plan Act, H.R. 3631 The State Stockpile Act, H. R. 5846 Protecting America from Seasonal and Pandemic, Influenza Act of 2023 (the Influenza Act) Clinical Lab Fee Schedule H.R. 2377 and S. 1000. Saving Access to Laboratory Services Act (SALSA) and H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023 FY25 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2024-07-17T12:18:20-04:00
3196349 STANFORD UNIVERSITY 74a1b3ad-29a4-4038-95be-df4651dca167 Q2 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2024 second_quarter MED HR 2389 Resident Physician Shortage Reduction Act of 2023 Antiviral drug research / Antiviral Drug Discovery Centers HOUSE OF REPRESENTATIVES,SENATE   120000 0 0 2024-07-17T14:20:33-04:00
3196421 CAPITOL COUNSEL LLC c571d586-2d69-4a8f-9c82-12522a6d49d1 Q2 CAPITOL COUNSEL LLC 313715 TEMPUS LABS, INC. 2024 second_quarter MED Issues regarding clinical lab fee schedule, regulation and reimbursement of AI in health care, health care privacy data, Clinical Trial Diversity, Data, and Cyber Security. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2024-07-17T14:41:10-04:00
3196485 DREXEL UNIVERSITY abe2d2e8-9a41-449a-b150-e0f88a88536a Q2 DREXEL UNIVERSITY 40032273 DREXEL UNIVERSITY 2024 second_quarter MED Advocacy around Medicaid reimbursements for high Medicaid medical facilities HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2024-07-17T14:53:17-04:00
3196938 FONTENOT HEALTH POLICY LLC f0bc39c2-08b6-47ea-adac-87c26b8d1084 Q2 FONTENOT HEALTH POLICY LLC 401107703 ORGANIZE DBA ORGANIZE ACTION NETWORK 2024 second_quarter MED Organ Procurement reforms; Revisions to the Outcme Measure Requirements for Organ Procurement Organizations; Final Rule (42 CFR, Part 486); Organ Procurement Organizations Conditions of Coverage; S. 1688/H.R. 2544 Securing the U.S. Organ Procurement and Transplantation Network Act Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,White House Office 10000   0 0 2024-07-17T16:40:46-04:00
3197074 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 1d3a0b45-2f0b-4afe-b898-9b24684779e0 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 DEFENSE HEALTH RESEARCH CONSORTIUM 2024 second_quarter MED H.R. 8774/S. unnumbered, FY25 Defense Appropriations Act, Defense Health Research Programs HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-07-17T17:39:52-04:00
3197103 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8eef7401-f7ea-44c1-9df1-3b176ff535ec Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 PANCREATIC CANCER ACTION NETWORK (PANCAN) 2024 second_quarter MED H.R. 8774/S. unnumbered, FY25 Defense Appropriations Act, Peer-Reviewed Pancreatic Cancer Research Program; H.R. 9029/S. unnumbered, FY25 Labor-Health and Human Services-Education Act, NIH research on pancreatic cancer HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-07-17T17:46:25-04:00
3197107 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2d6d1e43-5303-4003-9ad2-0ad0502c5aef Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 FOUNDATION FOR PERIPHERAL NEUROPATHY 2024 second_quarter MED H.R. 8774/S. unnumbered, FY25 Defense Appropriations Act, DoD funding for peripheral neuropathy research; H.R. 9029/S. unnumbered, FY25 Labor-Health and Human Services-Education Act, NIH research on peripheral neuropathy HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2024-07-17T17:48:18-04:00
3197117 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 82b627cf-eb86-4e4f-8100-101e5dba4200 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2024 second_quarter MED H.R. 8774/S. unnumbered, FY25 Defense Appropriations Act, Tuberous Sclerosis Complex Research Program; H.R. 9029/S. unnumbered, FY25 Labor-Health and Human Services-Education Act, NIH and CDC funding for tuberous sclerosis complex research and surveillance HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2024-07-17T17:54:21-04:00
3197120 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 5b982d08-78d2-4517-a250-c20099fc6d1f Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 KIDNEYCAN 2024 second_quarter MED H.R. 9029/S. unnumbered, FY25 Labor-Health and Human Services-Education Act, kidney cancer research at NIH HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2024-07-17T17:55:35-04:00
3197125 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c2b0ea58-c562-42a6-843c-94ddbcf9e3c5 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 VHL ALLIANCE 2024 second_quarter MED H.R. 8774/S. unnumbered, FY25 Defense Appropriation, DoD research on Von Hippel-Lindau syndrome; H.R. 9029/S. unnumbered, FY25 Labor-Health and Human Services-Education Act, NIH research on Von Hippel-Lindau syndrome HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-07-17T17:57:34-04:00
3197130 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 17581873-8d27-44eb-a685-988955942d53 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL CMV FOUNDATION 2024 second_quarter MED H.R. 8774/S. unnumbered, FY25 Defense Appropriations Act, DoD research on congenital CMV; H.R. 9029/S. unnumbered, FY25 Labor-Health and Human Services-Education Act, NIH research on CMV and CDC and HRSA support for CMV testing and surveillance HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2024-07-17T17:59:53-04:00
3197262 COVINGTON & BURLING LLP 2e3d3527-2d54-4932-9c3c-3dc5780488ab Q2 COVINGTON & BURLING LLP 11195 RWE ALLIANCE INC. 2024 second_quarter MED Real-world health data and analytics policy. HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2024-07-17T19:49:24-04:00
3198041 COVINGTON & BURLING LLP 3fd2bcb4-806b-437c-add1-1375230c83d5 Q2 COVINGTON & BURLING LLP 11195 AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA) 2024 second_quarter MED Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation; VALID Act (H.R. 2369) HOUSE OF REPRESENTATIVES 40000   0 0 2024-07-18T10:21:44-04:00
3198219 DA VINCI GROUP 38d70dbf-4102-4943-8a37-d9d82a474fa3 Q2 DA VINCI GROUP 11548 KAI MEDICAL LABORATORY 2024 second_quarter MED Funding for Clinical Research & Diagnostics Programs HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2024-07-18T10:49:29-04:00
3198243 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 24d511a4-36a6-4089-a84a-155a54288b87 Q2 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 400265214 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 2024 second_quarter MED Supporting funding for NIH, ARPA-H, CDC, HRSA, SAMHSA, ASPR, and DOD medical research. HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   325000 0 0 2024-07-18T10:52:24-04:00
3198264 UNIVERSITY OF IOWA ac1ebc26-865b-41a9-b177-9d715982b55c Q2 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2024 second_quarter MED N.A. HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2024-07-18T10:53:13-04:00
3198476 MARSHFIELD CLINIC HEALTH SYSTEM dd20268b-b316-4f37-93ca-df90e222861a Q2 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2024 second_quarter MED research support, agriculture, farm safety, child care and agriculture communities HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2024-07-18T11:30:06-04:00
3198530 NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH a5c3b813-5a55-4e57-9852-d3db375a6105 Q2 NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH 26557 NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH 2024 second_quarter MED Support funding for biomedical research HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2024-07-18T11:37:10-04:00
3198815 CASE WESTERN RESERVE UNIVERSITY 0a62696f-fbec-4d1a-8d6e-1de5ade6467f Q2 CASE WESTERN RESERVE UNIVERSITY 8418 CASE WESTERN RESERVE UNIVERSITY 2024 second_quarter MED FY25 House and Senate Appropriations. East Palestine Health Impact Monitoring Act of 2024 (HR 8537 & S. 4045), NIH Funding, COVID Research, opioid prevention & research, Prion Center, brain health, neurodegeneration research, neuropsychiatry, scope of nursing, nursing research, nursing workforce development programs, telehealth, racial disparities research, social determinants of health, maternal and infant health and mortality, Clinical and Translational Sciences Awards (CTSA), ARPA-H, Cancer Research, Foreign Influence Issues. HOUSE OF REPRESENTATIVES,SENATE   130000 0 0 2024-07-18T12:40:11-04:00
3198912 NATIONAL MULTIPLE SCLEROSIS SOCIETY 0a5a8bea-a3ac-4083-9e00-e5eb6d2f23c3 Q2 NATIONAL MULTIPLE SCLEROSIS SOCIETY 69674 NATIONAL MULTIPLE SCLEROSIS SOCIETY 2024 second_quarter MED S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage The Biosimilar Red Tape Elimination Act, monitor legislation U.S. HOUSE OF REPRESENTATIVES, U.S. Senate, Natl Institutes of Health (NIH), Defense - Dept of (DOD), Food & Drug Administration (FDA), Veterans Affairs - Dept of (VA) Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   41572 0 0 2024-07-18T12:57:22-04:00
3199049 NATIONAL NURSES UNITED 5679895f-1ec4-4fde-99ca-3b16605520b9 Q2 NATIONAL NURSES UNITED 40021153 NATIONAL NURSES UNITED 2024 second_quarter MED S.1113 Support for Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act S.1176 Support for The Workplace Violence Prevention for Health Care and Social Service Workers Act S.3744 Support for The Health ACCESS Act S.3860 Support for Nurse Overtime and Patient Safety Act S.4046 Support for VA Employee Fairness Act H.R.2530 Support Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act H.R.2663 Support The Workplace Violence Prevention for Health Care and Social Service Workers Act H.R.3421 Support The Medicare for All Act H.R.4328 Support National Nursing Shortage Task Force Act H.R.9200 Support for The Stop Nurse Shortages Act Support for Medicare for All Oppose HICPAC/CDC infection control draft guidelines and calling for inclusion of labor in working group Oppose CDC planning to shorten isolation timeframes for Covid-19 to less than five days Discuss issues related to AI and the Nursing Workforce Discuss concerns related to VA Privatization and hiring freeze Urge the Department of Labor (DOL) to expeditiously advance the development of an enforceable, permanent infectious diseases standard by the Occupational Safety and Health Administration (OSHA) Urge CDC and HICPAC to protect health care workers and patients from infectious diseases. Support the Biden administration's march-in rights framework to lower prescription drug prices and call for it to be strengthened. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Occupational Safety & Health Administration (OSHA),Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE,White House Office   100000 0 0 2024-07-18T13:18:32-04:00
3199190 THE JACKSON LABORATORY 415733fe-966c-4f92-9d0c-c0bf4edef25b Q2 THE JACKSON LABORATORY 401104723 THE JACKSON LABORATORY 2024 second_quarter MED Issues related to biomedical research. Animal model use in biomedical research. HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE   30000 0 0 2024-07-18T13:37:06-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2078.107ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API